• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Women With Liver Cancer Less Likely Than Men to Receive Liver Transplant

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 9, 2024.

By Lori Solomon HealthDay Reporter

MONDAY, Sept. 9, 2024 -- Women with hepatocellular carcinoma (HCC) are less likely to receive a deceased-donor liver transplant (DDLT) and more likely to die while wait-listed than men, according to a study published online Sept. 4 in JAMA Surgery.

David C. Cron, M.D., from Massachusetts General Hospital in Boston, and colleagues examined whether there are sex- or size-based disparities in access to DDLT. The analysis included 31,725 U.S. adult wait-listed liver transplant candidates receiving exception scores for HCC (Jan. 1, 2010, to March 2, 2023).

The researchers found that compared with men, women had a lower one-year cumulative incidence of DDLT (50.8 versus 54.0 percent) and a higher one-year cumulative incidence of death or delisting for health deterioration (16.2 versus 15.0 percent). Compared with men, women had a lower incidence of DDLT after adjustment, but without accounting for size (subdistribution hazard ratio [SHR], 0.92; 95 percent confidence interval [CI], 0.89 to 0.95), as well as a higher incidence of death or delisting (SHR, 1.06; 95 percent CI, 1.00 to 1.13). When adjusting for height and weight, there was no association seen between female sex and incidence of DDLT or death or delisting, overall, but short women (<166 cm) were still less likely to undergo a transplant (SHR, 0.93; 95 percent CI, 0.88 to 0.99).

"These findings suggest that for liver transplant candidates wait-listed with exception scores, additional changes to allocation policy are needed to resolve the sex disparity, including solutions to improve access to livers for smaller candidates," the authors write.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted September 2024

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.